The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 · Blood · 7,721 citations
https://doi.org/10.1182/blood-2016-01-643569
S
Stefano Pileri
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.0K
Papers
57.3K
Citations
114
h-index
474
i10-index
Stefano Pileri is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Chronic Lymphocytic Leukemia Research & Viral-associated cancers and disorders. The author has an h-index of 114, co-authored 864 publications.
ORCID: 0000-0001-8032-5128Papers by this author
worksThe International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
2022 · Blood · 1,387 citations
https://doi.org/10.1182/blood.2022015851
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
2015 · Cancer Cell · 435 citations
https://doi.org/10.1016/j.ccell.2015.03.006
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions
2017 · Blood Cancer Journal · 229 citations
https://doi.org/10.1038/bcj.2017.85
Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network
2009 · Journal of Hematopathology · 173 citations
https://doi.org/10.1007/s12308-009-0036-x
Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma
2021 · Nature Communications · 42 citations
https://doi.org/10.1038/s41467-021-25379-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat